Founded in 2011, and named for Dr. Charlotte Denman Lozier (1844–1870), an early feminist and contemporary of Susan B. Anthony and a model and inspiration for medicine, science, and research devoted to the cause of life, Charlotte Lozier Institute (CLI) brings together physicians, sociologists, statisticians, and policy researchers to do both original and interpretative research on a wide range of life issues.
The Charlotte Lozier Institute is committed to bringing the power of science, medicine, and research to bear in life-related policymaking, media, and debates to promote a culture and polity of life.
Find Out More
PIVOT is a new initiative of the University of Kansas Cancer Center to infuse greater patient engagement into all aspects of the Center. PIVOT stands for Patient and Investigator Voices Organizing Together because the ultimate goal is to encourage patients and investigators to “learn and link” together to conduct research that better meets patients’ needs and improves their ability to feel well, function and survive.
In July 2013, the Midwest Stem Cell Therapy Center (MSCTC) was created by Kansas Legislature with the mission to facilitate existing research and therapy on a global level, as well as to establish a frontier for other research and therapies for patients suffering from diseases.
Funded initially through State appropriation, the Center also operates off the generosity of donors through the University of Kansas Endowment Association. The 15-member advisory board is composed of members appointed by the governer, the House, Senate, Board of Regents and several other stakeholder entities.
Adult stem cell treatments have been used clinically to successfully treat leukemia and related bone/blood cancers using bone marrow transplantation. KU Medical Center has been involved in research using the solid part of the umbilical cord (Wharton’s jelly).
Besides KU Medical Center, other institutions around the state have also initiated adult stem cell research projects. However, before the MSCTC, there was no systematic mechanism for Kansans to receive adult stem cell therapy (other than bone marrow transplants for a few conditions) in the state or in the region, nor was there a coordinated center to translate basic stem cell research findings into clinical applications. The MSCTC is also working to educate the public, as well as medical professionals about adult stem cell therapeutic options, currently available or in development, that could benefit patients in need.